LUZZAGO, STEFANO
LUZZAGO, STEFANO
Dipartimento di Oncologia ed Emato-Oncologia
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer
2019 S. Knipper, A. Pecoraro, C. Palumbo, G. Rosiello, S. Luzzago, Z. Tian, A. Briganti, F. Saad, D. Tilki, M. Graefen, P.I. Karakiewicz
A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor
2022 F.A. Mistretta, O. de Cobelli, P. Verze, F. Botticelli, L. Jannello, S. Luzzago, G. Cozzi, R. Bianchi, E. Di Trapani, M. Ferro, G. Cordima, D. Bottero, D.V. Matei, V. Mirone, G. Musi
A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients
2020 F.A. Mistretta, S. Luzzago, L.O. Molendini, M. Ferro, E. Dossena, F. Mastrilli, G. Musi, O. de Cobelli
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging
2021 E. Di Trapani, S. Luzzago, G. Peveri, M. Catellani, M. Ferro, G. Cordima, F.A. Mistretta, R. Bianchi, G. Cozzi, S. Alessi, D.V. Matei, V. Bagnardi, G. Petralia, G. Musi, O. De Cobelli
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings
2020 S. Luzzago, O. de Cobelli, G. Cozzi, G. Peveri, V. Bagnardi, M. Catellani, E. Di Trapani, F.A. Mistretta, P. Pricolo, A. Conti, S. Alessi, G. Marvaso, M. Ferro, D. Matei, G. Renne, B. Jereczek-Fossa, G. Petralia, G. Musi
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma
2021 V.M. Schuettfort, D. D'Andrea, F. Quhal, H. Mostafaei, E. Laukhtina, K. Mori, F. Konig, M. Rink, M. Abufaraj, P.I. Karakiewicz, S. Luzzago, M. Roupret, D. Enikeev, K. Zimmermann, M. Deuker, M. Moschini, R. Sari Motlagh, N.C. Grossmann, S. Katayama, B. Pradere, S.F. Shariat
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG
2022 R. Contieri, R. Hurle, M. Paciotti, P. Casale, A. Saita, F. Porpiglia, C. Fiori, B. Barone, F. Crocetto, G. Lucarelli, G.M. Busetto, F. DEL GIUDICE, M. Maggi, F. Cantiello, R. Damiano, M. Borghesi, P. Bove, R. Bertolo, R. Papalia, A. Mari, S. Luzzago, F.A. Mistretta, F. Soria, P. Gontero, M. Marchioni, E. LA CIVITA, D. Terracciano, G.I. Russo, L. Schips, S. Perdonà, V. Mirone, O.S. Tataru, G. Musi, M.D. Vartolomei, R. Autorino, E. Montanari, O. DE COBELLI, M. Ferro
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG
2022 R. Contieri, R. Hurle, M. Paciotti, P. Casale, A. Saita, F. Porpiglia, C. Fiori, B. Barone, F. Crocetto, G. Lucarelli, G.M. Busetto, F. Del Giudice, M. Maggi, F. Cantiello, R. Damiano, M. Borghesi, P. Bove, R. Bertolo, R. Papalia, A. Mari, S. Luzzago, F.A. Mistretta, F. Soria, P. Gontero, M. Marchioni, E. LA Civita, D. Terracciano, G.I. Russo, L. Schips, S. Perdonà, V. Mirone, O.S. Tataru, G. Musi, M.D. Vartolomei, R. Autorino, E. Montanari, O. DE Cobelli, M. Ferro
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies
2021 S. Luzzago, M.L. Piccinelli, G. Marvaso, E. Laukhtina, N. Miura, V.M. Schuettfort, K. Mori, A. Aydh, M. Ferro, F.A. Mistretta, N. Fusco, G. Petralia, B.A. Jereczek-Fossa, S.F. Shariat, P.I. Karakiewicz, O. de Cobelli, G. Musi
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?
2020 G. Marvaso, M. Montesano, G. Corrao, S.P. De Angelis, S. Gandini, G.C. Mazzola, M. Augugliaro, J. Franzetti, D. Zerini, M. Pepa, S. Luzzago, F.A. Mistretta, G. Musi, F. Nole, O. De Cobelli, R. Orecchia, B.A. Jereczek-Fossa
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy
2021 S. Alessi, R. Maggioni, S. Luzzago, A. Colombo, P. Pricolo, P.E. Summers, G. Saia, M. Manzoni, G. Renne, G. Marvaso, O. De Cobelli, M. Bellomi, B.A. Jereczek-Fossa, G. Petralia
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review
2023 M. Ferro, F. Crocetto, B. Barone, F. Del Giudice, M. Maggi, G. Lucarelli, G.M. Busetto, R. Autorino, M. Marchioni, F. Cantiello, F. Crocerossa, S. Luzzago, M. Piccinelli, F.A. Mistretta, M. Tozzi, L. Schips, U.G. Falagario, A. Veccia, M.D. Vartolomei, G. Musi, O. de Cobelli, E. Montanari, O.S. Tătaru
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years : A population-based analysis
2020 A. Pecoraro, S. Knipper, C. Palumbo, G. Rosiello, S. Luzzago, Z. Tian, S.F. Shariat, F. Saad, A. Briganti, C. Fiori, F. Porpiglia, P.I. Karakiewicz
Assessment of psim (Prostatic systemic inflammatory markers) score in predicting pathologic features at robotic radical prostatectomy in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance
2021 M. Ferro, G. Musi, D.V. Matei, A.F. Mistretta, S. Luzzago, G. Cozzi, R. Bianchi, E. Di Trapani, A. Cioffi, G. Lucarelli, G.M. Busetto, F. Del Giudice, G.I. Russo, M. Di Mauro, A. Porreca, G. Renne, M. Catellani, D. Bottero, A. Brescia, G. Cordima, O. de Cobelli
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
2022 M.L. Piccinelli, S. Luzzago, G. Marvaso, E. Laukhtina, N. Miura, V.M. Schuettfort, K. Mori, A. Colombo, M. Ferro, F.A. Mistretta, N. Fusco, G. Petralia, B.A. Jereczek-Fossa, S.F. Shariat, P.I. Karakiewicz, O. de Cobelli, G. Musi
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients
2020 S. Luzzago, C. Palumbo, G. Rosiello, S. Knipper, A. Pecoraro, F.A. Mistretta, Z. Tian, G. Musi, E. Montanari, D. Soulieres, S.F. Shariat, F. Saad, A. Briganti, O. de Cobelli, P.I. Karakiewicz
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma
2020 E. Laukhtina, B. Pradere, D. D'Andrea, G. Rosiello, S. Luzzago, A. Pecoraro, C. Palumbo, S. Knipper, P.I. Karakiewicz, V. Margulis, F. Quhal, R. Sari Motlagh, H. Mostafaei, K. Mori, S. Kimura, D. Enikeev, S.F. Shariat
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study
2021 M. Ferro, M. Marchioni, G. Lucarelli, V.M. Dorin, F. Soria, D. Terracciano, F.A. Mistretta, S. Luzzago, C. Buonerba, F. Cantiello, A. Mari, A. Minervini, A. Veccia, A. Antonelli, G. Musi, R. Hurle, G.M. Busetto, F. Del Giudice, B.I. Chung, F. Berardinelli, S. Perdonà, P. Del Prete, V. Mirone, M. Borghesi, A. Porreca, P. Bove, R. Autorino, N. Crisan, A.R. Abu Farhan, M. Battaglia, P. Ditonno, G.I. Russo, M. Muto, R. Damiano, M. Manfredi, F. Porpiglia, O. De Cobelli, L. Schips
Bladder cancer incidence rates and trends in young adults aged 20-39 years
2020 C. Palumbo, A. Pecoraro, G. Rosiello, S. Luzzago, M. Deuker, F. Stolzenbach, Z. Tian, S.F. Shariat, C. Simeone, A. Briganti, F. Saad, A. Berruti, A. Antonelli, P.I. Karakiewicz
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center
2020 E. Di Trapani, G. Musi, M. Ferro, G. Cordima, F.A. Mistretta, S. Luzzago, R. Bianchi, G. Cozzi, S. Alessi, M. Catellani, D.V. Matei, B.A. Jereczek-Fossa, G. Petralia, O. De Cobelli